Literature DB >> 3510226

Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma.

K Tsunoda, K Abe, T Goto, M Yasujima, M Sato, K Omata, M Seino, K Yoshinaga.   

Abstract

To investigate the effect of aging on the renin-angiotensin-aldosterone system, plasma renin substrate concentrations (PRSC); plasma total, active, and inactive renin concentrations (TRC, ARC, and IRC); PRA; and plasma aldosterone concentrations (PAC) were measured simultaneously in 60 normal subjects, 18-84 yr old. PRSC was measured by the addition of excess human renal renin. ARC and TRC after trypsin activation were measured by adding sheep renin substrate; IRC was calculated by subtracting ARC from TRC. The active renin ratio was calculated as follows: ARC/TRC X 100%. PRA and PAC were measured by RIA. There were no significant changes in PRSC, TRC, IRC, and PRA to PAC ratio with aging. Both ARC and active renin ratio fell significantly with aging (r = 0.46 and P less than 0.01; and r = 0.54 and P less than 0.01, respectively). PRA and PAC also tended to decrease with aging (r = 0.35 and P less than 0.01; and r = 0.59 and P less than 0.01, respectively). A significant positive correlation was found between PRA and ARC (r = 0.72; P less than 0.001). PRA was also correlated with PAC. In conclusion, the age-related decrease in PRA is not due to the change in PRSC, but is mainly due to the fall in ARC. Decreased conversion of inactive to active renin might be responsible in part for the reduced ARC in the elderly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510226     DOI: 10.1210/jcem-62-2-384

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.

Authors:  Guoshu Yin; Shaoling Zhang; Li Yan; Muchao Wu; Mingtong Xu; Feng Li; Hua Cheng
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 2.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Sodium disorders in the elderly.

Authors:  Naureen Tareen; David Martins; Glenn Nagami; Barton Levine; Keith C Norris
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

Review 4.  Renal senescence in 2008: progress and challenges.

Authors:  Xin J Zhou; Ramesh Saxena; Zhihong Liu; N D Vaziri; Fred G Silva
Journal:  Int Urol Nephrol       Date:  2008-06-27       Impact factor: 2.370

5.  Potential effects of age on screening for primary aldosteronism.

Authors:  Q Luo; N F Li; X G Yao; D L Zhang; S F Y Abulikemu; G J Chang; K M Zhou; G L Wang; M H Wang; W J Ouyang; Q Y Cheng; Y Jia
Journal:  J Hum Hypertens       Date:  2015-04-16       Impact factor: 3.012

Review 6.  Clinical aspects of changes in water and sodium homeostasis in the elderly.

Authors:  Christian A Koch; Tibor Fulop
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

7.  Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity.

Authors:  Taiki Hayashi; Zhen Zhang; Ghaith Al-Eyd; Atsushi Sasaki; Masanori Yasuda; Masafumi Oyama; Celso E Gomez-Sanchez; Hirotaka Asakura; Tsugio Seki; Kuniaki Mukai; Koshiro Nishimoto
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-08       Impact factor: 4.292

Review 8.  Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications.

Authors:  J H Bauer
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 9.  The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Authors:  G Neil Thomas; Paul Chan; Brian Tomlinson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

10.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.